Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Total expenses | 166 | 4,085 | 4,478 | 470 | 60 |
| Operating Income | -166 | -4,085 | -4,478 | -470 | -60 |
| Interest Expense | 20 | 75 | 35 | 114 | 64 |
| Other Income | -146 | -103 | -6 | -312 | 0 |
| Pre-tax Income | -333 | -4,263 | -4,519 | -896 | -124 |
| Net Income Continuous | -333 | -4,263 | -4,519 | -896 | -124 |
| Net Income | $-333 | $-4,263 | $-4,519 | $-896 | $-124 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Basic Total Ops | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
| EBITDA(a) | $-151 | $-4,012 | $-4,445 | $-362 | $1 |